The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction

Diabetology and Metabolic Syndrome

Volumn 8, Issue 1, 2016, Pages

  Barbarash, Olga ^a   Gruzdeva, Olga ^a   Uchasova, Evgenya ^a   Dyleva, Yulia ^a   Belik, Ekaterina ^a   Akbasheva, Olga ^b   Karetnikova, Victoria ^a   Kokov, Alexander ^a  

^a RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

^b SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Adipokines; Adipose tissue; Carbohydrate metabolism disorders; Diabetes; Inflammation percutaneous coronary intervention; Insulin resistance; Myocardial infarction

Indexed keywords

ADIPOCYTOKINE;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; HEART INFARCTION; HUMAN; HYPERLEPTINEMIA; INSULIN RESISTANCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 85007603285     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-016-0136-6     Document Type: Article

References (17)

1. Alexopoulos N, Katritsis D, Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis. 2014;233(1):104-12.
2. Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M, et al. Why visceral fat is bad: Mechanisms of the metabolic syndrome. Obesity. 2006;14:16-9.
3. Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM, et al. Association of Visceral Adipose Tissue with Incident Myocardial Infarction in Older Men and Women. Am J Epidemiol. 2004;160(8):741-9.
4. Fontes-Carvalho R, Fontes-Oliveira M, Sampaio F, Mancio J, Bettencourt N, Teixeira M, et al. Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction. Am J Cardiol. 2014;114(11):1663-8.
5. Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85:609-17.
6. Dedov II, Shestakova MV. Algorithms for specialized medical care to patients with diabetes. Sakharnyy diabet. 2013;6:120 (Russian).
7. Chumakova GA, Veselovskaya NG, Kozarenko AA, Vorobyov YV. The morphology, structure and function of the heart in obese. Russ J Cardiol. 2012;4(96):93-9 (Russian).
8. Thygesen K, Alpert J, White HD. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation. 2007;116:2634-53.
9. Bessesen DH. Update on obesity. J Clin Endocrinol Metab. 2008;93:2027-34.
10. Oreopoulos A, Padwal R, Norris CM, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Effect of obesity on short-and long-term mortality postcoronary revascularization: A meta-analysis. Obesity (silver spring). 2008;16:442-50.
11. Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP, et al. Mortality prediction by surrogates of body composition: An examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol. 2012;175:793-803.
12. Gruzdeva OV, Barbarash OL, Akbasheva OE, Palicheva EI, Dyleva Y, Belik EV, et al. The detection of leptin and metabolic markers of insulin resistance in patients with cardiac infarction. Klin Lab Diagn. 2013;2:12-6 (Russian).
13. Khafaji HA, Bener AB, Rizk NM. Al Suwaidi J. Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings. BMC Res Notes. 2012;29(5):262.
14. Soodini GR, Hamdy O. Adiponectin and leptin in relation to insulin sensitivity. Metab Syndr Relat Disord. 2004;2:114-23.
15. Rajapurohitam V, Javadov S. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol. 2006;41(2):265-74.
16. Wallander M, Soderberg S, Norhammar A. Leptin: A predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabet Med. 2008;25(8):949-55.
17. Lessard J, Laforest S, Pelletier M, Leboeuf M, Blackburn L, Tchernof A. Low abdominal subcutaneous preadipocyte adipogenesis is associated with visceral obesity, visceral adipocyte hypertrophy, and a dysmetabolic state. Adipocyte. 2014;3:197-205.